Medigus launches ADS offering

• Medigus (NASDAQ:MDGS) intends to offer its ADSs for sale in a public offering.
• Underwriter's over-allotment is an additional 15% of ADSs.
• Net proceeds will be used for working capital and general corporate purposes.
• Actual size, price or terms of the offering are not yet determined.
• Aegis Capital is acting as sole bookrunner.